Table 1.
Trial | No. of patients | Treatment | Follow up (months) | Follow up (method) | Change in LVEF (%) (Treatment vs. control) | p-value |
---|---|---|---|---|---|---|
MAGIC [10] | 97 | myoblasts | 6 | ECHO | 3.4(−0.3; 12.4)/5.2(−4.4; 11) vs. 4.4(0.2; 7.3) | NS |
REPAIR-AMI [57] | 204 | BMC | 4 | LV-Angio | 5.5±7.3 vs. 3.0±6.5 | <0.01 |
Janssens [58] | 67 | BMC | 4 | MRI | 3.4±6.9 vs. 2.2±7.3 | NS |
BOOST* [59, 60] | 60 | BMC | 6/60 | MRI | 6.7±6.5 vs. 0.7±8.1/−2.5±11.9 vs. −3.3±9.5 | 0.003/NS |
Chen [61] | 69 | BMMC | 6 | LV-Angio | 18 vs 6 | 0.01 |
BMC= bone marrow stem cells
BMMC = bone marrow mesenchymal stem cells
LVEF = left ventricular ejection fraction
LV-Angio = left ventricular angiography
MRI = magnetic resonance imagin
NS = not significant
= not double blinded